The most consequential decision in a dental practice sale is usually made before any negotiation begins, and many sellers do not realize they are making it: which kind of buyer to sell to. A DSO deal and a private buyer sale are not two versions of the same transaction. They are different transactions — different economics, different documents, different lives after closing.
Dentists who regret their exits rarely regret the price. They regret the path. This article lays out how the two paths actually differ, where the regret comes from, and how to choose deliberately.
Why dentists choose the wrong exit
Three patterns account for most exit regret.
Overweighting the headline multiple. DSO offers frequently carry higher headline numbers, and the headline does its job: it gets the LOI signed. But the multiple says nothing about how much arrives as cash, when, or under what conditions.
Ignoring employment and control changes. The seller is not just selling an asset; in most DSO deals, the seller is also signing up for years of employment under new management. Sellers evaluate the sale carefully and the employment casually — then live in the employment.
No post-closing life planning. “What do I want my Tuesday to look like in year three?” is the question that should drive exit selection. It is usually asked for the first time in year two, after the documents are signed.
Anatomy of a DSO deal
The standard DSO structure has four components, and they work as a system.
Partial cash at close — typically a substantial portion of the price, but not all of it. Mandatory rollover equity — the seller takes part of the price in equity of the DSO or its parent, aligning the seller with the platform’s future performance and its eventual recapitalization. Multi-year employment — the seller commits to continue practicing, usually three to five years, with compensation reset to employee economics. Operational control shifts — scheduling, staffing, supplies, and systems migrate to the DSO’s playbook on the DSO’s timeline.
None of this is hidden; it is all in the documents. The pattern among regretful sellers is not that they were deceived — it is that they priced the cash and skimmed the rest.
The economics deserve particular attention. Rollover equity can be the best or worst part of a DSO deal depending on the platform’s trajectory and the equity’s terms: what class, what rights, what happens on exit, what happens if the seller leaves early. These are diligence questions pointed at the buyer — and sellers are often surprised to learn they should be running diligence at all.
Control and restrictions in DSO deals
Three categories of restriction shape post-closing life under DSO ownership.
Clinical autonomy limits — formally, clinical decisions remain the dentist’s; practically, the systems around those decisions (scheduling density, supply formularies, treatment-planning targets, staffing models) are now someone else’s. Non-competes and non-solicits — broad covenants are standard, and they outlast the employment term. Exit penalties — leaving before the employment term ends typically triggers real costs: forfeited equity, clawbacks, or both. The seller who assumes they can simply leave if it does not work out has usually not read the documents that say otherwise.
Anatomy of a private buyer sale
The private buyer transaction — selling to an individual dentist or small group — runs on a different logic: mostly cash at closing, a shorter transition period measured in months rather than years, and a cleaner exit with the seller’s ongoing role limited to handover rather than employment.
The trade-offs are real. Indemnities and escrows: with no platform absorbing risk, private buyers negotiate seller protections carefully, and the seller stands behind the representations personally. Seller financing risk: private deals sometimes ask the seller to carry part of the price as a note — which means the seller’s payout depends on the buyer’s success. Limited upside: there is no rollover equity and no second bite at a future recapitalization. The price at closing is the price.
The reality check, side by side
Stripped to essentials, the comparison looks like this:
Cash at close: private buyer deals deliver more of the price as cash at closing; DSO deals deliver less now with more promised later. Long-term upside: DSO deals carry it (through rollover equity); private sales do not. Control: private sales end the seller’s obligations quickly; DSO deals extend them for years. Complexity: DSO documents are an order of magnitude heavier. Regret risk: concentrated on the DSO side — not because DSO deals are bad, but because they have more moving parts to misjudge.
And the multiple myth deserves repeating: the higher DSO multiple is the price of the structure that comes with it. Comparing a 7x structured offer against a 5.5x cash offer on the multiples alone is comparing the part of the deal designed to be compared — and ignoring the parts designed not to be.
Where the regret actually comes from
Among sellers who regret DSO exits, three scenarios recur. Income drops after the guarantee period — initial compensation guarantees expire, and employee economics arrive in full. Non-competes block future plans — the seller discovers in year four that the covenant forecloses the part-time arrangement or new location they had assumed. Culture mismatch — the practice the seller built no longer runs the way the seller built it, and the seller still works there.
Each of these was knowable — and negotiable — at the LOI stage.
How to choose: four factors and a test
Four personal factors do most of the work in exit selection.
Career horizon. A dentist with ten years left has time to recover from a wrong choice and time to benefit from rollover upside. A dentist with three years left has neither. Burnout level. Burnout argues for the cleaner exit, even at a lower number — an exhausted seller locked into a five-year employment term is the single most reliable regret scenario. Risk tolerance. Rollover equity is a concentrated, illiquid position in a leveraged platform. Some sellers are comfortable with that; many only think they are. Autonomy preference. A dentist who has owned their practice for twenty years should be honest about how employment will feel — under systems they did not choose.
Then apply the five-year test: write down, concretely, what you want years one through five after closing to look like — clinical hours, income needs, location, obligations. Year 1: transition intensity under either path. Years 2–3: where the paths diverge — employee under DSO systems versus fully exited. Years 4–5: where covenants, equity vesting, and guarantee expirations actually bite. An exit that cannot pass the five-year test on paper will not pass it in practice.
What proper exit planning involves
Deliberate exit selection has three components: pre-LOI strategy — deciding which buyer universe to engage before going to market, not after offers arrive; offer comparison modeling — translating each offer into net, risk-adjusted, after-tax proceeds plus obligations, so structurally different offers can be compared honestly; and long-term risk analysis — reading the employment terms, covenants, and equity documents as carefully as the purchase agreement, because for DSO sellers they are the purchase agreement.
This is also where deal counsel matters most. The documents in a DSO transaction are drafted by the DSO’s lawyers, for the DSO’s benefit, and refined across hundreds of acquisitions. A seller’s counsel who handles these transactions regularly knows where the standard terms flex — and which “standard” terms are not.
Questions to ask the DSO before signing
Sellers run diligence on practices; few think to run it on buyers. Before signing a DSO LOI, the seller should have real answers — in writing where possible — to a short list of questions.
On the equity: What class of equity is the rollover, and how does it rank against the sponsor’s? What happened to seller equity in the platform’s last recapitalization, if there has been one? What happens to unvested or vested equity if the seller leaves early, is terminated without cause, or is terminated for cause — and how is cause defined?
On the economics: What does compensation look like in year two, after any guarantee expires, for sellers who joined the platform two and three years ago? Can the DSO provide references — selling dentists who joined twelve or more months ago and will take a call?
On operations: Which clinical and operational decisions formally migrate to the platform, on what timeline? What is the platform’s associate retention record at acquired locations?
A reputable DSO can answer all of these and will respect a seller who asks. Evasive answers are themselves information — gathered at the only stage where the seller can still act on it.
The takeaway
DSO versus private buyer is not a question of which is better. It is a question of which is better for this seller, at this career stage, with this risk tolerance and this picture of life after closing. The sellers who get it right decide the path first and negotiate the deal second.
The full webinar deck, DSO Deals vs. Private Buyer Sales: Choosing the Right Exit Path, is available as a PDF download.
If you are weighing exit options — or holding a DSO offer right now — a confidential strategy conversation can clarify the comparison before anything is signed. Schedule a confidential consultation.
This article is for informational purposes only and is not legal advice. No attorney-client relationship is formed by reading it.